Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 5/20 | 0.74 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.64 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | KMO | O15229 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.46 |
| ▸ | FEN1 | P39748 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.44 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29493845 | 1.00 | AHR (0.74) | AHRESR2CYP1B1CYP1A2CYP2C9 | |
| Water SCHEMBL11023201 | 0.97 | AHR (0.70) | AHRESR2CYP1B1CYP1A2CYP2C9 | |
| Sulfur Dioxide SCHEMBL27851594 | 0.91 | AHR (0.61) | AHRESR2CYP1B1CYP1A2CYP2C9 | |
| Boric Acid SCHEMBL30873596 | 0.91 | AHR (0.61) | AHRESR2CYP1B1CYP1A2CYP2C9 | |
| SCHEMBL27940579 | 0.89 | AHR (0.58) | AHRESR2CYP1B1CYP1A2CYP2C9 | |
| SCHEMBL8652196 | 0.89 | AHR (0.58) | AHRESR2CYP1B1CYP1A2ALOX5 | |
| Urea SCHEMBL27889450 | 0.87 | ESR2 (0.57) | AHRESR2CYP1B1CYP1A2CYP2C9 | |
| SCHEMBL137915 | 0.86 | AHR (1.00) | AHRESR2CYP1B1MEN1KMT2A | |
| SCHEMBL29769221 | 0.86 | AHR (1.00) | AHRESR2CYP1B1MEN1KMT2A | |
| SCHEMBL8652195 | 0.84 | CYP2A6 (0.71) | AHRESR2CYP1B1ADORA1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3881907-A1 | METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION | Université de Lille (FR) | 2021-09-22 | — | — | EP | claimed |
| CN-110612119-A | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | 西雅图儿童医院（DBA西雅图儿童研究所） | 2019-12-24 | — | — | CN | claimed |
| WO-2018148224-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) | 2018-08-16 | — | — | WO | claimed |
| CN-102911619-A | Assistant composite activated by ultraviolet light and adhesive containing composite | GUANGDONG HENGDA NEW MATERIALS TECHNOLOGY CO LTD | 2013-02-06 | — | — | CN | claimed |
| EP-0968739-B1 | Method for decomposing halogenated aliphatic and aromatic compounds | CANON KK (JP) | 2010-06-16 | — | — | EP | claimed |
| US-7304065-B2 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2007-12-04 | — | — | US | claimed |
| CN-101068773-A | Melanin concentrating hormone antagonists | PROCTER & GAMBLE (US) | 2007-11-07 | — | — | CN | claimed |
| EP-1667958-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-14 | — | — | EP | claimed |
| WO-2005033063-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-14 | — | — | WO | claimed |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-07 | — | — | US | claimed |
| EP-1005881-B1 | Method and apparatus for decomposing halogenated aliphatic hydrocarbon compounds or aromatic compounds | CANON KK (JP) | 2005-01-19 | — | — | EP | claimed |
| US-6616815-B2 | Contacting under irradiation with light a medium containing at least one of a halogenated aliphatic hydrocarbon compound and an aromatic compound with functional water produced by electrolysis of water containing an electrolyte | CANON KABUSHIKI KAISHA (JP) | 2003-09-09 | — | — | US | claimed |
| US-20030164286-A1 | Apparatus for decomposing halogenated aliphatic hydrocarbon compounds or aromatic compounds | CANON KABUSHIKI KAISHA (JP) | 2003-09-04 | — | — | US | claimed |
| US-20030148501-A1 | Compositions and methods useful in bioremediation of polychlorinated biphenyls | NATIONAL SCIENCE FOUNDATION | 2003-08-07 | — | — | US | claimed |
| US-6537797-B1 | Isolated bacterium that utilizes 2,3-dichloro-biphenyl as a sole carbon source | INDIANA UNIVERSITY, ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE | 2003-03-25 | — | — | US | claimed |
| US-20020163135-A1 | METHOD FOR DECOMPOSING HALOGENATED ALIPHATIC HYDROCARBON COMPOUNDS OR AROMATIC COMPOUNDS, METHOD FOR CLEANING MEDIUM CONTAMINATED WITH AT LEAST ONE OF THESE COMPOUNDS, AND APPARATUS FOR THESE | CANON KABUSHIKI KAISHA (JP) | 2002-11-07 | — | — | US | claimed |
| US-20020130030-A1 | METHOD OF DECOMPOSING HALOGENATED ALIPHATIC HYDROCARBON COMPOUNDS OR AROMATIC COMPOUNDS AND APPARATUS TO BE USED FOR THE SAME AS WELL AS METHOD OF CLARIFYING EXHAUST GAS AND APPARATUS TO BE USED FOR THE SAME | CANON KABUSHIKI KAISHA (JP) | 2002-09-19 | — | — | US | claimed |
| EP-1005881-A1 | Method and apparatus for decomposing halogenated aliphatic hydrocarbon compounds or aromatic compounds | CANON KABUSHIKI KAISHA (JP) | 2000-06-07 | — | — | EP | claimed |
| EP-0968739-A1 | Method and apparatus for decomposing halogenated aliphatic and aromatic compounds | CANON KABUSHIKI KAISHA (JP) | 2000-01-05 | — | — | EP | claimed |
| US-5559131-A | ANTAGONISTS OF TACHYKININS AT THE NEUROKININ 2 RECEPTOR, ANTIASTHMA | ZENECA LIMITED (GB) | 1996-09-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030164286-A1 | Apparatus for decomposing halogenated aliphatic hydrocarbon compounds or aromatic compounds | AHR, ARNT, TRPA1 | AHR 1/4885ESR2 3033/4885CYP1B1 150/4885 |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | MCHR1, MCHR2, MC1R | AHR 663/4885ESR2 1314/4885CYP1B1 1061/4885 |
| US-20020130030-A1 | METHOD OF DECOMPOSING HALOGENATED ALIPHATIC HYDROCARBON COMPOUNDS OR AROMATIC COMPOUNDS AND APPARATUS TO BE USED FOR THE SAME AS WELL AS METHOD OF CLARIFYING EXHAUST GAS AND APPARATUS TO BE USED FOR THE SAME | AHR, ARNT, TRPA1 | AHR 1/4885ESR2 1116/4885CYP1B1 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.